Ignite Creation Date:
2024-05-05 @ 7:57 PM
Last Modification Date:
2024-10-26 @ 9:56 AM
Study NCT ID:
NCT00777608
Status:
COMPLETED
Last Update Posted:
2015-08-25
First Post:
2008-10-21
Brief Title:
A Study to Test the Performance of the CogState Computerized Neuropsychological Battery in Patients With Alzheimers Disease 0000-086COMPLETED
Sponsor:
Merck Sharp Dohme LLC
Organization:
Merck Sharp Dohme LLC
Study Overview
Official Title:
A Multicenter Randomized Double-Blind Placebo-Controlled Parallel-Group Trial With Placebo Run-In and an Open-Label Treatment Period to Evaluate the Performance of the CogState Computerized Neuropsychological Battery and the ADAS-Cog in Generally Cholinesterase-naive AD Patients
Status:
COMPLETED
Status Verified Date:
2015-08
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This study will evaluate the performance of the CogState computerized neuropsychological battery Alzheimers Disease Assessment Scale-Cognitive Subscale ADAS-cog and Alzheimers Disease Cooperative Study - Activities of Daily Living ADCS-ADL in participants with mild-to-moderate Alzheimers disease AD
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| 2008_573 | None | None | None |